Ghent University Academic Bibliography

Your filters: cql: issn exact "1942-0862"

Add to list
- Journal Article
- A1
- open access
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties

Hristo Svilenov (UGent) , Paolo Arosio, Tim Menzen, Peter Tessier and Pietro Sormanni

(2023) MABS. 15(1).
Add to list
- Journal Article
- A1
- open access
GlycoVHH : optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery

Loes van Schie (UGent) , Wander Van Breedam (UGent) , Charlotte Roels (UGent) , Bert Schepens (UGent) , Martin Frank, Ahmadreza Mehdipour (UGent) , Bram Laukens, Wim Nerinckx (UGent) , Francis Santens, Simon Devos (UGent) , et al.

(2023) MABS. 15(1).
Add to list
- Journal Article
- A1
- open access
Rapid production of a chimeric antibody-antigen fusion protein based on 2A-peptide cleavage and green fluorescent protein expression in CHO cells

Hans Van Der Weken (UGent) , Eric Cox (UGent) and Bert Devriendt (UGent)

(2019) MABS. 11(3). p.559-568
Add to list
Intracellular displacement of p53 using transactivation domain (p53 TAD) specific nanobodies

Anneleen Steels, Adriaan Verhelle (UGent) , Olivier Zwaenepoel (UGent) and Jan Gettemans (UGent)

(2018) MABS. 10(7). p.1045-1059
Add to list
- Journal Article
- A1
- open access
Personalized medicine with biologics for severe type 2 asthma : current status and future prospects

Marie Godar (UGent) , Christophe Blanchetot, Hans de Haard, Bart Lambrecht (UGent) and Guy Brusselle (UGent)

(2018) MABS. 10(1). p.34-45
Add to list
ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade

Karen Silence, Torsten Dreier, Mahan Moshir, Peter Ulrichts, Sofie ME Gabriels, Michael Saunders, Harald Wajant, Peter Brouckaert (UGent) , Leander Huyghe (UGent) , Tim Van Hauwermeiren, et al.

(2014) MABS. 6(2). p.523-532

Academic Bibliography

Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties

GlycoVHH : optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery

Rapid production of a chimeric antibody-antigen fusion protein based on 2A-peptide cleavage and green fluorescent protein expression in CHO cells

Intracellular displacement of p53 using transactivation domain (p53 TAD) specific nanobodies

Personalized medicine with biologics for severe type 2 asthma : current status and future prospects

ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade

Contents

Support

Contact